Vijaya Diagnostic Centre Limited Stock Price Today (NSE: VIJAYA)
Vijaya Diagnostic Centre Limited
Fundamental Score
Vijaya Diagnostic Centre Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vijaya Diagnostic Centre Limited share price today is ₹1483.40, down 0.93% on NSE/BSE as of 25 August 2026. Vijaya Diagnostic Centre Limited (VIJAYA) is a Mid-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹14.31K (Cr). The 52-week high for VIJAYA share price is ₹1521.30 and the 52-week low is ₹848.00. At a P/E ratio of 76.31x, VIJAYA is currently trading above its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 19.74% and a debt-to-equity ratio of 0.00.
Vijaya Diagnostic Centre Limited Share Price Chart — NSE/BSE Historical Performance
Vijaya Diagnostic Centre Limited share price chart: 9.82% return over the past month. 52-week high ₹1521.30, 52-week low ₹848.00.
Vijaya Diagnostic Centre Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1483.00 | ₹1499.80 | ₹1448.20 | ₹1483.40 | 1.89L (Cr) | |
| ₹1505.00 | ₹1521.30 | ₹1491.00 | ₹1497.30 | 92.77K (Cr) | |
| ₹1359.90 | ₹1359.90 | ₹1328.10 | ₹1344.40 | 2.53L (Cr) | |
| ₹1354.00 | ₹1375.00 | ₹1351.10 | ₹1372.00 | 80.75K (Cr) | |
| ₹1339.00 | ₹1363.30 | ₹1336.80 | ₹1359.10 | 65.93K (Cr) | |
| ₹1322.00 | ₹1357.80 | ₹1308.20 | ₹1350.80 | 84.86K (Cr) | |
| ₹1334.70 | ₹1348.50 | ₹1320.50 | ₹1331.30 | 89.02K (Cr) | |
| ₹1341.10 | ₹1379.40 | ₹1327.50 | ₹1334.70 | 1.76L (Cr) | |
| ₹1415.90 | ₹1436.80 | ₹1309.50 | ₹1341.30 | 8.64L (Cr) | |
| ₹1397.30 | ₹1440.00 | ₹1359.40 | ₹1412.50 | 3.91L (Cr) |
Vijaya Diagnostic Centre Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1505.00 | ₹1521.30 | ₹1448.20 | ₹1483.40 | -1.44% | |
| ₹1359.90 | ₹1440.00 | ₹1303.20 | ₹1344.40 | -1.14% | |
| ₹1318.60 | ₹1427.80 | ₹1224.50 | ₹1352.60 | +2.58% | |
| ₹1129.60 | ₹1379.30 | ₹1129.60 | ₹1308.50 | +15.84% | |
| ₹868.95 | ₹1135.00 | ₹852.60 | ₹1129.60 | +30.00% | |
| ₹977.00 | ₹991.60 | ₹848.00 | ₹861.40 | -11.83% | |
| ₹972.00 | ₹1037.00 | ₹937.40 | ₹1004.50 | +3.34% | |
| ₹1061.90 | ₹1069.50 | ₹918.30 | ₹958.70 | -9.72% | |
| ₹995.10 | ₹1112.40 | ₹954.00 | ₹1061.00 | +6.62% | |
| ₹990.90 | ₹1064.85 | ₹976.30 | ₹998.05 | +0.72% | |
| ₹1004.00 | ₹1030.00 | ₹959.90 | ₹988.65 | -1.53% | |
| ₹1020.00 | ₹1120.40 | ₹995.80 | ₹1000.00 | -1.96% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Vijaya Diagnostic Centre Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vijaya Diagnostic Centre Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VIJAYA across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (19.74%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.32%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (42.84%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (38.51%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (22.83%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 2.60)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹387.55 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (52.60%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 43.31%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 76.31x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (14.95x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Vijaya Diagnostic Centre Limited vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Vijaya Diagnostic Centre Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Vijaya Diagnostic Centre LimitedVijaya Diagnost...Selected✓ VIJAYA • 543350 | 67.8/100 | ₹1483.40₹1483 | ₹14307.85₹14307.85 | 76.31Average 76.3 Average | 19.74%Good 19.74% Good | 21.32%Excellent 21.32% Excellent | 0.00Excellent 0.0 Excellent | — — | — — | 0.14% |
Dr. Lal Path Labs Ltd.Dr. Lal Path La... LALPATHLAB • 539524 | 57.7/100 | ₹1913.70₹1914 | ₹28908.91₹28908.91 | 53.35Average 53.3 Average | 21.57%Excellent 21.57% Excellent | 27.62%Excellent 27.62% Excellent | 0.00Excellent 0.0 Excellent | 11.60%Good 11.60% Good | 11.81%Good 11.81% Good | 0.81% |
Metropolis Healthcare LimitedMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹566.70₹567 | ₹11858.49₹11858.49 | 58.81Average 58.8 Average | 13.36%Average 13.36% Average | 16.80%Good 16.80% Good | 0.01Excellent 0.0 Excellent | 0.74%Average 0.74% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LimitedThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹596.05₹596 | ₹8420.27₹8420.27 | 47.76Average 47.8 Average | 28.80%Excellent 28.80% Excellent | 35.47%Excellent 35.47% Excellent | 0.00Excellent 0.0 Excellent | — — | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LimitedKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹564.80₹565 | ₹1777.47₹1777.47 | 21.62Average 21.6 Average | 10.89%Average 10.89% Average | 13.05%Average 13.05% Average | 0.55Good 0.5 Good | — — | — — | 0.50% |
Suraksha Diagnostic LimitedSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹317.85₹318 | ₹1359.30₹1359.30 | 37.97Average 38.0 Average | 14.11%Average 14.11% Average | 16.82%Good 16.82% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% |
One Global Service Provider LimitedOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹546.20₹546 | ₹1178.25₹1178.25 | — — | — — | — — | — — | — — | — — | 0.00% |
3B Blackbio Dx Limited3B Blackbio Dx ... 3BBLACKBIO • 532067 | 60.3/100 | ₹1262.40₹1262 | ₹1079.13₹1079.13 | — — | — — | — — | — — | — — | — — | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹220.15₹220 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Aspira Pathlab & Diagnostics LimitedAspira Pathlab ... ASPIRA • 540788 | 11.9/100 | ₹93.70₹94 | ₹88.52₹88.52 | 1770.34Average 1770.3 Average | 0.51%Poor 0.51% Poor | 2.84%Poor 2.84% Poor | 0.27Excellent 0.3 Excellent | -48.50%Poor -48.50% Poor | 10.43%Good 10.43% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr. Lal Path Labs Ltd. share price28908.91 Cr
- Metropolis Healthcare Limited share price11858.49 Cr
- Thyrocare Technologies Limited share price8420.27 Cr
- Krsnaa Diagnostics Limited share price1777.47 Cr
- Suraksha Diagnostic Limited share price1359.30 Cr
Vijaya Diagnostic Centre Limited PE Ratio History
Historical price-to-earnings ratio for VIJAYA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹13.92 | ₹1061.00 | 76.2x |
| FY 2024 | ₹11.59 | ₹1056.85 | 91.2x |
| FY 2023 | ₹8.26 | ₹675.70 | 81.8x |
| FY 2022 | ₹10.69 | ₹437.15 | 40.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Vijaya Diagnostic Centre Limited Dividend History
Annual cash dividends paid by VIJAYA — dividend yield 0.14%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹10.26 Cr |
| FY 2024 | ₹10.23 Cr |
| FY 2023 | ₹10.21 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Vijaya Diagnostic Centre Limited Quarterly Performance
Latest quarterly metrics for VIJAYA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
22.83%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
38.51%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Vijaya Diagnostic Centre Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for VIJAYA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Vijaya Diagnostic Centre Limited Financial Statements
Annual income statement, balance sheet and cash flow for Vijaya Diagnostic Centre Limited (VIJAYA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Vijaya Diagnostic Centre Limited
About VIJAYA (Vijaya Diagnostic Centre Limited)
Vijaya Diagnostic Centre Ltd is a prominent healthcare service provider renowned for its comprehensive and advanced diagnostic solutions. Boasting a wide spectrum of offerings, Vij...aya caters to diverse medical needs, from routine screenings to intricate investigations. They are equipped with cutting-edge technology and staffed by a team of highly skilled professionals, ensuring accurate and reliable results. Driven by a commitment to patient well-being, Vijaya Diagnostic Centre strives to be a trusted partner in healthcare, empowering individuals and medical practitioners with the insights needed for informed decisions and effective treatment strategies. Their commitment extends beyond just generating data; they aim to be a crucial link in the chain of patient care, providing clarity and support throughout the diagnostic journey. The core of Vijaya Diagnostic Centre's services lies in its extensive laboratory testing capabilities. This encompasses an array of disciplines, including pathology, microbiology, and advanced molecular diagnostics. Beyond traditional laboratory tests, Vijaya offers a wide array of imaging services, spanning from X-rays and ultrasounds to sophisticated CT scans, MRI scans, and PET/CT scans. Their dedication to technological advancement is evident in their provision of specialized services such as MRI-3T, ensuring high-resolution imaging for precise diagnoses. By integrating these diverse modalities, Vijaya Diagnostic Centre strives to provide a holistic diagnostic experience under one roof, simplifying the process for patients and clinicians alike. Their dedication to quality and innovation positions them as a leader in the diagnostic landscape. Further enhancing accessibility and convenience, Vijaya Diagnostic Centre extends its services beyond the confines of its physical locations. With comprehensive health checkup packages designed to suit varied needs, they enable proactive health management. Recognizing the importance of convenience in today's fast-paced world, Vijaya also offers home sample collection services, bringing diagnostic care directly to patients' doorsteps. This patient-centric approach underscores their dedication to providing seamless and accessible healthcare solutions. By combining advanced technology with a strong focus on patient comfort and convenience, Vijaya Diagnostic Centre is committed to revolutionizing the diagnostic experience and empowering individuals to take control of their health.
Company Details
Key Leadership
Corporate Events
Latest News
VIJAYA Share Price: Frequently Asked Questions
What is the current share price of Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited (VIJAYA) trades at ₹1483.40 on NSE and BSE. Market cap ₹14.31K (Cr). Educational data only.
What is the P/E ratio of Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited has a P/E of 76.31x vs industry average 42.23x.
What is the Bull Run score for Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited has a Bull Run score of 67.8/100 based on 25+ financial parameters.
Does Vijaya Diagnostic Centre Limited pay dividends?
Vijaya Diagnostic Centre Limited has a dividend yield of 0.14%. Past dividends don't guarantee future payments.
What is the ROE of Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited has ROE of 19.74%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Vijaya Diagnostic Centre Limited?
Vijaya Diagnostic Centre Limited has debt-to-equity of 0.00.
Is Vijaya Diagnostic Centre Limited a good investment?
Bull Run gives Vijaya Diagnostic Centre Limited a score of 67.8/100. This is not investment advice — consult a SEBI-registered advisor.